Neuroinflammation may have beneficial or detrimental net effects on the cognitive outcome of Alzheimer disease (AD) patients. PET imaging with 18-kDa translocator protein (TSPO) enables longitudinal monitoring of microglial activation in vivo. Methods: We compiled serial PET measures of TSPO and amyloid with terminal cognitive assessment (water maze) in an AD transgenic mouse model (PS2APP) from 8 to 13 mo of age, followed by immunohistochemical analyses of microglia, amyloid, and synaptic density. Results: Better cognitive outcome and higher synaptic density in PS2APP mice was predicted by higher TSPO expression at 8 mo. The progression of TSPO activation to 13 mo also showed a moderate association with spared cognition, but amyloidosis did not correlate with the cognitive outcome, regardless of the time point. Conclusion: This first PET investigation with longitudinal TSPO and amyloid PET together with terminal cognitive testing in an AD mouse model indicates that continuing microglial response seems to impart preserved cognitive performance.
Neuroinflammation may have beneficial or detrimental net effects on the cognitive outcome of Alzheimer disease (AD) patients. PET imaging with 18-kDa translocator protein (TSPO) enables longitudinal monitoring of microglial activation in vivo. Methods: We compiled serial PET measures of TSPO and amyloid with terminal cognitive assessment (water maze) in an AD transgenic mouse model (PS2APP) from 8 to 13 mo of age, followed by immunohistochemical analyses of microglia, amyloid, and synaptic density. Results: Better cognitive outcome and higher synaptic density in PS2APP mice was predicted by higher TSPO expression at 8 mo. The progression of TSPO activation to 13 mo also showed a moderate association with spared cognition, but amyloidosis did not correlate with the cognitive outcome, regardless of the time point. Conclusion: This first PET investigation with longitudinal TSPO and amyloid PET together with terminal cognitive testing in an ADmouse model indicates that continuing microglial response seems to impart preserved cognitive performance.
Authors: Christian Sacher; Tanja Blume; Leonie Beyer; Finn Peters; Florian Eckenweber; Carmelo Sgobio; Maximilian Deussing; Nathalie L Albert; Marcus Unterrainer; Simon Lindner; Franz-Josef Gildehaus; Barbara von Ungern-Sternberg; Irena Brzak; Ulf Neumann; Takashi Saito; Takaomi C Saido; Peter Bartenstein; Axel Rominger; Jochen Herms; Matthias Brendel Journal: J Nucl Med Date: 2019-07-13 Impact factor: 10.057
Authors: Tomás R Guilarte; Alexander N Rodichkin; Jennifer L McGlothan; Arlet Maria Acanda De La Rocha; Diana J Azzam Journal: Pharmacol Ther Date: 2021-11-27 Impact factor: 13.400
Authors: Florian Eckenweber; Jose Medina-Luque; Tanja Blume; Christian Sacher; Gloria Biechele; Karin Wind; Maximilian Deussing; Nils Briel; Simon Lindner; Guido Boening; Barbara von Ungern-Sternberg; Marcus Unterrainer; Nathalie L Albert; Andreas Zwergal; Johannes Levin; Peter Bartenstein; Paul Cumming; Axel Rominger; Günter U Höglinger; Jochen Herms; Matthias Brendel Journal: J Neuroinflammation Date: 2020-07-13 Impact factor: 8.322
Authors: Myoung-Gwi Ryou; Xiaoan Chen; Ming Cai; Hong Wang; Marianna E Jung; Daniel B Metzger; Robert T Mallet; Xiangrong Shi Journal: Front Aging Neurosci Date: 2021-07-01 Impact factor: 5.750
Authors: Kai Schlepckow; Kathryn M Monroe; Gernot Kleinberger; Ludovico Cantuti-Castelvetri; Samira Parhizkar; Dan Xia; Michael Willem; Georg Werner; Nadine Pettkus; Bettina Brunner; Alice Sülzen; Brigitte Nuscher; Heike Hampel; Xianyuan Xiang; Regina Feederle; Sabina Tahirovic; Joshua I Park; Rachel Prorok; Cathal Mahon; Chun-Chi Liang; Ju Shi; Do Jin Kim; Hanna Sabelström; Fen Huang; Gilbert Di Paolo; Mikael Simons; Joseph W Lewcock; Christian Haass Journal: EMBO Mol Med Date: 2020-03-10 Impact factor: 12.137
Authors: Benjamin B Tournier; Stergios Tsartsalis; Kelly Ceyzériat; Ben H Fraser; Marie-Claude Grégoire; Enikö Kövari; Philippe Millet Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472